506
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Antihyperhomocysteinemic Activity of an Ethanol Extract from Embelia ribes. in Albino Rats

&
Pages 283-287 | Accepted 04 Sep 2007, Published online: 07 Oct 2008
 

Abstract

An ethanol extract from Embelia ribes. Burm (Myrsinaceae) fruits was investigated for its antihyperhomocysteinemic and lipid-lowering potential in methionine-induced hyperhomocysteinemia rats. Hyperhomocysteinemia was induced by methionine (1 g/kg, p.o., 30 days) through drinking water in male albino rats. A significant (p < 0.01) increase in homocysteine, lactate dehydrogenase, total cholesterol, triglycerides, and low-density lipoprotein levels in serum and lipid peroxides levels in heart homogenates with a concomitant decrease in serum high-density lipoprotein and myocardial glutathione levels were observed in pathogenic control rats compared with normal healthy control rats. Furthermore, ethanol Embelia ribes. extract (100 and 200 mg/kg, p.o., 30 days) treatment in both the doses significantly reversed all the above-mentioned parameters compared with pathogenic control rats. The results of test drug were comparable with folic acid (100 mg/kg, p.o.), a standard antihyperhomocysteinemic agent. The results indicated that ethanol Embelia ribes. extract has significant antihyperhomocysteinemic and lipid-lowering potential in hyperhomocysteinemic rats.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.